Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Össur hf

BATS-CHIXE:OSSRC
Snowflake Description

Mediocre balance sheet with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
OSSRC
BATS-CHIXE
DKK18B
Market Cap
  1. Home
  2. GB
  3. Healthcare
Company description

Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle-East, Africa, the Americas, and the Asia-Pacific. The last earnings update was 64 days ago. More info.


Add to Portfolio Compare Print
  • Össur hf has significant price volatility in the past 3 months.
OSSRC Share Price and Events
7 Day Returns
4.1%
BATS-CHIXE:OSSRC
-1.2%
GB Medical Equipment
0.1%
GB Market
1 Year Returns
24.4%
BATS-CHIXE:OSSRC
-0.3%
GB Medical Equipment
-23.6%
GB Market
OSSRC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Össur hf (OSSRC) 4.1% 1.7% -25.2% 24.4% 57.6% 93.8%
GB Medical Equipment -1.2% -12% -19.1% -0.3% -2.3% 20.9%
GB Market 0.1% -15.5% -27% -23.6% -24.3% -23.5%
1 Year Return vs Industry and Market
  • OSSRC outperformed the Medical Equipment industry which returned -0.3% over the past year.
  • OSSRC outperformed the Market in United Kingdom of Great Britain and Northern Ireland which returned -23.6% over the past year.
Price Volatility
OSSRC
Industry
5yr Volatility vs Market

OSSRC Value

 Is Össur hf undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Össur hf to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Össur hf.

BATS-CHIXE:OSSRC Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7%
Perpetual Growth Rate 10-Year GB Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BATS-CHIXE:OSSRC
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 7%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.81
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.808 (1 + (1- 20%) (14.01%))
0.932
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.93
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.53% + (0.932 * 6.96%)
7.02%

Discounted Cash Flow Calculation for BATS-CHIXE:OSSRC using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Össur hf is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

BATS-CHIXE:OSSRC DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.02%)
2020 55.30 Analyst x3 51.67
2021 99.67 Analyst x3 87.03
2022 105.00 Analyst x3 85.67
2023 117.00 Analyst x1 89.21
2024 122.00 Analyst x1 86.92
2025 125.47 Est @ 2.85% 83.54
2026 128.18 Est @ 2.15% 79.74
2027 130.31 Est @ 1.67% 75.76
2028 132.04 Est @ 1.33% 71.73
2029 133.47 Est @ 1.09% 67.75
Present value of next 10 years cash flows $779.00
BATS-CHIXE:OSSRC DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $133.47 × (1 + 0.53%) ÷ (7.02% – 0.53%)
$2,069.01
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $2,069.01 ÷ (1 + 7.02%)10
$1,050.29
BATS-CHIXE:OSSRC Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $779.00 + $1,050.29
$1,829.29
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,829.29 / 421.45
$4.34
BATS-CHIXE:OSSRC Discount to Share Price
Calculation Result
Exchange Rate USD/DKK
(Reporting currency to currency of CPSE:OSSR)
6.858
Value per Share
(DKK)
= Value per Share in USD x Exchange Rate (USD/DKK)
= $4.34 x 6.858
DKK29.77
Non-primary Listing Adjustment Factor 1 share in BATS-CHIXE:OSSRC represents 1.00239x of CPSE:OSSR
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.00239x
Value per Share
(Listing Adjusted, DKK)
= Value per Share (DKK) x Listing Adjustment Factor
= DKK 29.77 x 1.00239
DKK29.84
Value per share (DKK) From above. DKK29.84
Current discount Discount to share price of DKK42.05
= -1 x (DKK42.05 - DKK29.84) / DKK29.84
-40.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Össur hf is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Össur hf's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Össur hf's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BATS-CHIXE:OSSRC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $0.16
CPSE:OSSR Share Price ** CPSE (2020-04-07) in DKK DKK41.95
CPSE:OSSR Share Price converted to USD reporting currency Exchange rate (DKK/ USD) 0.146 $6.12
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PE Ratio Median Figure of 11 Publicly-Listed Medical Equipment Companies 25.55x
United Kingdom of Great Britain and Northern Ireland Market PE Ratio Median Figure of 748 Publicly-Listed Companies 12.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Össur hf.

BATS-CHIXE:OSSRC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CPSE:OSSR Share Price ÷ EPS (both in USD)

= 6.12 ÷ 0.16

39.22x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Össur hf is overvalued based on earnings compared to the GB Medical Equipment industry average.
  • Össur hf is overvalued based on earnings compared to the United Kingdom of Great Britain and Northern Ireland market.
Price based on expected Growth
Does Össur hf's expected growth come at a high price?
Raw Data
BATS-CHIXE:OSSRC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 39.22x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts
15.2%per year
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PEG Ratio Median Figure of 8 Publicly-Listed Medical Equipment Companies 2x
United Kingdom of Great Britain and Northern Ireland Market PEG Ratio Median Figure of 517 Publicly-Listed Companies 0.99x

*Line of best fit is calculated by linear regression .

BATS-CHIXE:OSSRC PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 39.22x ÷ 15.2%

2.57x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Össur hf is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Össur hf's assets?
Raw Data
BATS-CHIXE:OSSRC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $1.34
CPSE:OSSR Share Price * CPSE (2020-04-07) in DKK DKK41.95
CPSE:OSSR Share Price converted to USD reporting currency Exchange rate (DKK/ USD) 0.146 $6.12
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry PB Ratio Median Figure of 20 Publicly-Listed Medical Equipment Companies 2.83x
United Kingdom of Great Britain and Northern Ireland Market PB Ratio Median Figure of 1,323 Publicly-Listed Companies 1.11x
BATS-CHIXE:OSSRC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CPSE:OSSR Share Price ÷ Book Value per Share (both in USD)

= 6.12 ÷ 1.34

4.57x

* Primary Listing of Össur hf.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Össur hf is overvalued based on assets compared to the GB Medical Equipment industry average.
X
Value checks
We assess Össur hf's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Össur hf has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

OSSRC Future Performance

 How is Össur hf expected to perform in the next 1 to 3 years based on estimates from 3 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
15.2%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Össur hf expected to grow at an attractive rate?
  • Össur hf's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Össur hf's earnings growth is positive but not above the United Kingdom of Great Britain and Northern Ireland market average.
  • Össur hf's revenue growth is expected to exceed the United Kingdom of Great Britain and Northern Ireland market average.
Annual Growth Rates Comparison
Raw Data
BATS-CHIXE:OSSRC Future Growth Rates Data Sources
Data Point Source Value (per year)
BATS-CHIXE:OSSRC Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 3 Analysts 15.2%
BATS-CHIXE:OSSRC Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 3 Analysts 5.4%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 21.1%
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United Kingdom of Great Britain and Northern Ireland Market Earnings Growth Rate Market Cap Weighted Average 15.5%
United Kingdom of Great Britain and Northern Ireland Market Revenue Growth Rate Market Cap Weighted Average 2.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BATS-CHIXE:OSSRC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BATS-CHIXE:OSSRC Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 897 1
2023-12-31 843 1
2022-12-31 795 147 101 3
2021-12-31 754 140 90 3
2020-12-31 701 106 71 3
2020-04-08
BATS-CHIXE:OSSRC Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 686 95 66
2019-09-30 675 102 83
2019-06-30 652 84 85
2019-03-31 631 76 83
2018-12-31 613 69 80
2018-09-30 599 78 69
2018-06-30 593 71 64
2018-03-31 579 72 58
2017-12-31 569 74 58
2017-09-30 553 64 49
2017-06-30 543 68 51
2017-03-31 538 61 52

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Össur hf's earnings are expected to grow by 15.2% yearly, however this is not considered high growth (20% yearly).
  • Össur hf's revenue is expected to grow by 5.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BATS-CHIXE:OSSRC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below

All data from Össur hf Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:OSSRC Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31
2023-12-31 0.31 0.31 0.31 1.00
2022-12-31 0.23 0.26 0.21 3.00
2021-12-31 0.21 0.23 0.19 3.00
2020-12-31 0.16 0.20 0.14 3.00
2020-04-08
BATS-CHIXE:OSSRC Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 0.16
2019-09-30 0.20
2019-06-30 0.21
2019-03-31 0.20
2018-12-31 0.19
2018-09-30 0.16
2018-06-30 0.15
2018-03-31 0.13
2017-12-31 0.13
2017-09-30 0.11
2017-06-30 0.12
2017-03-31 0.12

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Össur hf is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Össur hf's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United Kingdom of Great Britain and Northern Ireland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Össur hf has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

OSSRC Past Performance

  How has Össur hf performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Össur hf's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Össur hf's year on year earnings growth rate has been positive over the past 5 years.
  • Össur hf's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Össur hf's 1-year earnings growth is negative, it can't be compared to the GB Medical Equipment industry average.
Earnings and Revenue History
Össur hf's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Össur hf Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BATS-CHIXE:OSSRC Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 686.26 66.04 301.50 31.33
2019-09-30 674.59 83.01 295.71 31.32
2019-06-30 652.17 84.99 283.96 31.15
2019-03-31 631.32 83.05 273.87 31.13
2018-12-31 612.88 79.75 264.93 31.36
2018-09-30 598.84 68.88 258.73 30.81
2018-06-30 592.53 64.16 253.78 31.24
2018-03-31 579.24 57.53 251.88 30.19
2017-12-31 568.62 57.65 245.42 28.91
2017-09-30 553.24 48.93 245.74 28.79
2017-06-30 543.50 50.85 239.16 26.92
2017-03-31 537.56 52.35 240.44 24.96
2016-12-31 520.75 51.03 233.25 23.17
2016-09-30 506.87 49.31 227.34 20.85
2016-06-30 495.02 50.37 219.18 19.89
2016-03-31 483.44 51.29 209.34 19.09
2015-12-31 483.03 51.24 207.51 18.36
2015-09-30 487.81 53.59 209.22 18.37
2015-06-30 497.01 55.35 212.84 18.23
2015-03-31 502.24 57.16 214.27 18.52
2014-12-31 509.36 59.45 217.95 19.43
2014-09-30 508.53 58.11 216.84 20.34
2014-06-30 486.76 54.77 207.03 20.47
2014-03-31 460.08 45.82 198.84 20.84
2013-12-31 436.27 40.48 188.56 21.54
2013-09-30 406.20 35.40 177.75 21.94
2013-06-30 399.98 33.28 176.81 22.66

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Össur hf has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Össur hf used its assets less efficiently than the GB Medical Equipment industry average last year based on Return on Assets.
  • Össur hf's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Össur hf's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Össur hf has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

OSSRC Health

 How is Össur hf's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Össur hf's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Össur hf is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Össur hf's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Össur hf's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Össur hf Company Filings, last reported 3 months ago.

BATS-CHIXE:OSSRC Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 568.96 251.12 58.61
2019-09-30 553.79 222.77 55.88
2019-06-30 552.35 225.51 37.06
2019-03-31 533.25 223.88 32.72
2018-12-31 537.54 235.48 55.71
2018-09-30 511.00 182.20 39.83
2018-06-30 499.52 172.41 38.13
2018-03-31 496.83 187.60 41.86
2017-12-31 500.46 158.69 37.27
2017-09-30 480.34 175.76 34.73
2017-06-30 467.86 184.97 38.59
2017-03-31 448.96 183.71 34.77
2016-12-31 467.19 154.53 35.09
2016-09-30 465.56 169.63 30.35
2016-06-30 454.98 165.83 42.45
2016-03-31 466.58 98.57 30.11
2015-12-31 463.03 84.10 25.71
2015-09-30 461.41 90.81 21.22
2015-06-30 450.10 112.54 26.93
2015-03-31 424.72 118.50 21.20
2014-12-31 442.12 122.29 28.48
2014-09-30 467.80 109.77 26.25
2014-06-30 465.69 140.41 41.78
2014-03-31 450.24 147.55 30.87
2013-12-31 448.04 150.75 41.77
2013-09-30 433.09 160.27 80.82
2013-06-30 409.81 105.23 18.92
  • Össur hf's level of debt (44.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (27.7% vs 44.1% today).
  • Debt is well covered by operating cash flow (37.9%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 14.5x coverage).
X
Financial health checks
We assess Össur hf's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Össur hf has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

OSSRC Dividends

 What is Össur hf's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.35%
Current annual income from Össur hf dividends. Estimated to be 0.46% next year.
If you bought DKK2,000 of Össur hf shares you are expected to receive DKK7 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Össur hf's pays a lower dividend yield than the bottom 25% of dividend payers in United Kingdom of Great Britain and Northern Ireland (2.59%).
  • Össur hf's dividend is below the markets top 25% of dividend payers in United Kingdom of Great Britain and Northern Ireland (7.08%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BATS-CHIXE:OSSRC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 3 Analyst Estimates (S&P Global) See Below
United Kingdom of Great Britain and Northern Ireland Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2.2%
United Kingdom of Great Britain and Northern Ireland Market Average Dividend Yield Market Cap Weighted Average of 588 Stocks 5.6%
United Kingdom of Great Britain and Northern Ireland Minimum Threshold Dividend Yield 10th Percentile 1.3%
United Kingdom of Great Britain and Northern Ireland Bottom 25% Dividend Yield 25th Percentile 2.6%
United Kingdom of Great Britain and Northern Ireland Top 25% Dividend Yield 75th Percentile 7.1%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BATS-CHIXE:OSSRC Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31 0.04 3.00
2021-12-31 0.03 3.00
2020-12-31 0.02 3.00
2020-04-08
BATS-CHIXE:OSSRC Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2020-02-20 0.021 0.361
2019-03-07 0.020 0.322
2018-02-15 0.020 0.434
2017-02-16 0.017 0.416
2016-02-18 0.017 0.478
2015-02-19 0.017 0.536
2015-02-05 0.018 0.616
2014-02-28 0.015 0.676
2013-02-22 0.017 1.123

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Össur hf is not paying a notable dividend for United Kingdom of Great Britain and Northern Ireland, therefore no need to check if the payments are stable.
  • Össur hf is not paying a notable dividend for United Kingdom of Great Britain and Northern Ireland, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Össur hf's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Össur hf's dividends as it is not paying a notable one for United Kingdom of Great Britain and Northern Ireland.
Future Payout to shareholders
  • No need to calculate the sustainability of Össur hf's dividends in 3 years as they are not expected to pay a notable one for United Kingdom of Great Britain and Northern Ireland.
X
Income/ dividend checks
We assess Össur hf's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Össur hf afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Össur hf has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

OSSRC Management

 What is the CEO of Össur hf's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jón Sigurðsson
COMPENSATION $1,694,000
AGE 63
TENURE AS CEO 24.3 years
CEO Bio

Mr. Jón Sigurðsson has been the Chief Executive Officer and President of Gibaud SAS since 1996. Mr. Sigurðsson has been Senior Vice President of Procurement at Promens Canada Inc. and Promens hf. since July 2007. He was the Chief Financial Officer of Promens since its establishment in 2005 and at Sæplast since 2004. From 1999 to 2004, He was the Director of Investment at Framtak Investment Bank, Iceland before which he worked for the Coca Cola from 1991 to1999, first as Chief Financial Officer for the Bottler in Iceland and later as the Manager of Financial Analyzis and Bottlers support and Manager in Business Development at the Divisional office in Oslo, Norway. From 1986 to 1991 He served as Chief Financial Officer of Hans Petersen hf. (Kodak in Iceland) and Business Consultant for Hagvangur Consulting 1980 to 1986. Previously, he served as Chief Financial Officer of Alafoss hf. from 1989 to 1992. He worked as Head of the International Division of Eimskip hf. from 1986 to 1989 and as an Engineer of Bang & Olufsen AS in Denmark from 1982 to 1984. He was the Commercial Counsellor for the Icelandic Trade Council in New York from 1992 to 1996. He serves as Chairman of the Icelandic American Chamber of Commerce. He has been the Independent Chairman of the Board at Vitrolife AB (publ) since May 02, 2019 and has been its Independent Director since 2015. He serves as a Board member of Rio Tinto Alcan in Iceland. He is a Board Member of the Icelandic Trade Council, Icelandic Chamber of Commerce, Reykjavík University, Sjoklaedagerdin hf. and Samherji. He has a B.Sc. degree in Industrial Engineering from the Technical School in Odense, Denmark and a Master’s degree in Business Administration from the United States International University in San Diego. He has a Cand. oecon. degree from the University of Iceland.

CEO Compensation
  • Jón's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Jón's remuneration is lower than average for companies of similar size in United Kingdom of Great Britain and Northern Ireland.
Management Team Tenure

Average tenure and age of the Össur hf management team in years:

5.5
Average Tenure
56
Average Age
  • The average tenure for the Össur hf management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Jón Sigurðsson

TITLE
CEO & President
COMPENSATION
$2M
AGE
63
TENURE
24.3 yrs

Ossur Kristinsson

TITLE
COMPENSATION
$25K
AGE
76

Sveinn Sölvason

TITLE
Chief Financial Officer
COMPENSATION
$221K
AGE
41
TENURE
6.9 yrs

Egill Jónsson

TITLE
Executive Vice President of Manufacturing & Operations
COMPENSATION
$444K
AGE
62

David Hreidarsson

TITLE
Investor Relations Manager

Sigurborg Arnarsdottir

TITLE
Compliance Officer
TENURE
18.3 yrs

Ólafur Gylfason

TITLE
Executive Vice President of Sales & Marketing
COMPENSATION
$600K
AGE
50
TENURE
4.2 yrs

Margrét Friðriksdóttir

TITLE
Executive Vice President of Human Resources & Corporate Strategy
COMPENSATION
$242K
AGE
41

Gudjon Karason

TITLE
Executive Vice President of Clinics
AGE
50
TENURE
2.4 yrs

Kristleifur Kristjansson

TITLE
Executive Vice President of Research & Development
AGE
64
TENURE
0.3 yrs
Board of Directors Tenure

Average tenure and age of the Össur hf board of directors in years:

11.3
Average Tenure
62
Average Age
  • The average tenure for the Össur hf board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Niels Jacobsen

TITLE
Chairman of the Board
COMPENSATION
$97K
AGE
62
TENURE
14.3 yrs

Kristján Ragnarsson

TITLE
Vice Chairman
COMPENSATION
$58K
AGE
76
TENURE
8.1 yrs

Arne Nielsen

TITLE
Director
COMPENSATION
$39K
AGE
51
TENURE
11.3 yrs

Svafa Grönfeldt

TITLE
Independent Director
COMPENSATION
$39K
AGE
54
TENURE
12.3 yrs

Guðbjörg Eggertsdóttir

TITLE
Independent Director
COMPENSATION
$39K
AGE
68
TENURE
7.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (DKK) Value (DKK)
X
Management checks
We assess Össur hf's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Össur hf has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

OSSRC News

Simply Wall St News

OSSRC Company Info

Description

Össur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle-East, Africa, the Americas, and the Asia-Pacific. The company’s prosthetics products comprise artificial limbs and related products for amputees; and lower and upper limb prosthetic components, including feet, knees, hands, liners, and other components. It also offers bracing and supports products, such as supporting devices for spinal, knee, hip, foot, ankle, and hands that are used primarily to support joints and other body parts for preventative and therapeutic purposes; and injury solutions to enhance the healing process of bone and soft tissue injuries. In addition, the company provides compression therapy products, such as compression socks, tights, and bandages used to apply pressure to the vascular system to enhance circulation and minimize swelling. Össur hf. markets its products under the CTi, Rebound, Miami, Innovator, Unloader, Iceross, Flex-Foot, and Total Knee brand names. The company sells its products through its direct sales networks and distributors. Össur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.

Details
Name: Össur hf.
OSSRC
Exchange: BATS-CHIXE
Founded: 1971
DKK17,637,798,298
421,452,767
Website: http://www.ossur.com
Address: Össur hf.
Grjothals 1-5,
Reykjavik,
110,
Iceland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CPSE OSSR Common Stock OMX Nordic Exchange Copenhagen DK DKK 21. Oct 1999
OTCPK OSSF.F Common Stock Pink Sheets LLC US USD 21. Oct 1999
LSE 0FIW Common Stock London Stock Exchange GB DKK 21. Oct 1999
BATS-CHIXE OSSRC Common Stock BATS 'Chi-X Europe' GB DKK 21. Oct 1999
OTCPK OSSU.Y SPONSORED ADR Pink Sheets LLC US USD 14. Dec 2011
Number of employees
Current staff
Staff numbers
3,449
Össur hf employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/08 00:33
End of day share price update: 2020/04/07 00:00
Last estimates confirmation: 2020/04/03
Last earnings filing: 2020/02/04
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.